James Jenrette

James Jenrette serves as a procurement professional within the FDA Office of Acquisition and Grant Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific and regulatory infrastructure. He manages a diverse portfolio of contracts focused on professional training, research support services, and specialized analytical equipment leasing, ensuring the FDA maintains cutting-edge capabilities in drug safety evaluation, toxicology, and regulatory science. His acquisitions directly enable laboratory operations, clinical research partnerships, and scientific workforce development, aligning procurement activities with the agency’s technical and operational priorities. Jenrette maintains consistent working relationships with key contractors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a preference for niche scientific service providers with deep expertise in regulatory compliance, preclinical research, and clinical trial support. These partnerships are typically non-competitive, performance-based engagements centered on specialized technical deliverables rather than commoditized goods, indicating a focus on high-value, mission-critical expertise rather than broad-based procurement. His contracting patterns show no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and domain expertise over socioeconomic preferences, prioritizing mission readiness and scientific rigor in vendor selection. While small business participation is not formally incentivized, the nature of the procurements often naturally involves specialized firms of limited size with niche certifications. Jenrette’s primary procurement focus lies in NAICS 611430 (professional and management development training), 813920 (professional organizations), 813910 (business associations), and 532490 (commercial equipment leasing). He routinely acquires advanced analytical instrumentation, regulatory training programs, and scientific consortium services essential to FDA’s laboratory operations and workforce competency. His domain expertise centers on regulatory science, toxicology, and clinical research support, ensuring procurement decisions align with the technical demands of FDA’s public health mandate.